,:

Ping-Li Mo1, Ming Lin2, Bo-Wen Gao3

  • 1Shenzhen Key Laboratory of Hospital Chinese Medicine Preparation, Shenzhen Traditional Chinese Medicine Hospital, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen 518033, Guangdong Province, China.

概括

本文献分析显示,肝细胞癌 (HCC) 瘤相关巨细胞 (TAM) 的研究正在迅速扩大,中国在全球贡献率领先,并确定了免疫逃避和免疫疗法等关键研究前沿.